Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder

This study assessed the efficacy, tolerability and safety of vortioxetine versus placebo in adults with recurrent major depressive disorder. This double-blind, randomized, placebo-controlled study included 608 patients [Montgomery–Åsberg Depression Rating Scale (MADRS) total score≥26 and Clinical Gl...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Boulenger, Jean-Philippe, Loft, Henrik, Olsen, Christina Kurre
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams And Wilkins 2014
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3979887/
https://ncbi.nlm.nih.gov/pubmed/24257717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0000000000000018
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky